Zebularine inhibits the growth of HeLa cervical cancer cells via cell cycle arrest and caspase-dependent apoptosis

Molecular Biology Reports

Volumn 39, Issue 10, 2012, Pages 9723-9731

  You, Bo Ra ^a   Park, Woo Hyun ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Apoptosis; Caspase; DNA methyltransferase; HeLa; Zebularine

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CYCLIN A; CYCLIN DEPENDENT KINASE 2; GLUTATHIONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; REACTIVE OXYGEN METABOLITE; ZEBULARINE;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL DEATH; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN CLEAVAGE; S PHASE CELL CYCLE CHECKPOINT; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE INHIBITORS; CASPASES; CELL PROLIFERATION; CYTIDINE; DNA MODIFICATION METHYLASES; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GLUTATHIONE; HELA CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MEMBRANE POTENTIAL, MITOCHONDRIAL; OLIGOPEPTIDES; REACTIVE OXYGEN SPECIES; S PHASE CELL CYCLE CHECKPOINTS; UTERINE CERVICAL NEOPLASMS;

EID: 84868525918     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1837-z     Document Type: Article

References (36)

1. Lee JY, Lee TH (2011) Effects of DNA methylation on the structure of nucleosomes. J Am Chem Soc. doi:10.1021/ja210273w
2. Gebhard C, Benner C, Ehrich M, Schwarzfischer L, Schilling E, Klug M, Dietmaier W, Thiede C, Holler E, Andreesen R, Rehli M (2010) General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells. Cancer Res 70(4):1398-1407. doi:10.1158/0008-5472. CAN-09-3406
3. Takeshima H, Yamashita S, Shimazu T, Ushijima T (2011) Effects of genome architecture and epigenetic factors on susceptibility of promoter CpG islands to aberrant DNA methylation induction. Genomics 98(3):182-188. doi:10.1016/j.ygeno. 2011. 06.003
4. Gan L, Chen S, Zhong J, Wang X, Lam EK, Liu X, Zhang J, Zhou T, Yu J, Si J, Wang L, Jin H (2011) ZIC1 is downregulated through promoter hypermethylation, and functions as a tumor suppressor gene in colorectal cancer. PLoS One 6(2):e16916. doi: 10.1371/journal.pone.0016916
5. Lin RK, Hsieh YS, Lin P, Hsu HS, Chen CY, Tang YA, Lee CF, Wang YC (2010) The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. J Clin Invest 120(2):521-532. doi:10.1172/JCI4070640706
6. Marques CJ, Joao Pinho M, Carvalho F, Bieche I, Barros A, Sousa M (2011) DNA methylation imprinting marks and DNA methyltransferase expression in human spermatogenic cell stages. Epigenetics 6(11):1354-1361. doi:10.4161/epi.6.11. 17993
7. Kobayashi Y, Absher DM, Gulzar ZG, Young SR, McKenney JK, Peehl DM, Brooks JD, Myers RM, Sherlock G (2011) DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer. Genome Res 21(7):1017-1027. doi:10.1101/gr.119487.110
8. Weisenberger DJ, Velicescu M, Cheng JC, Gonzales FA, Liang G, Jones PA (2004) Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation. Mol Cancer Res 2(1):62-72
9. Qu Y, Mu G, Wu Y, Dai X, Zhou F, Xu X, Wang Y, Wei F (2010) Overexpression of DNA methyltransferases 1, 3a, and 3b significantly correlates with retinoblastoma tumorigenesis. Am J Clin Pathol 134(5):826-834. doi:10.1309/AJCPHGQ69FXD FWII
10. Amara K, Ziadi S, Hachana M, Soltani N, Korbi S, Trimeche M (2010) DNA methyltransferase DNMT3b protein overexpression as a prognostic factor in patients with diffuse large B-cell lymphomas. Cancer Sci 101(7):1722-1730. doi:10.1111/j.1349-7006. 2010.01569.x
11. Gravina GL, Festuccia C, Marampon F, Popov VM, Pestell RG, Zani BM, Tombolini V (2010) Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation. Mol Cancer 9:305. doi:10.1186/1476-4598-9-305
12. Lim SP, Neilsen P, Kumar R, Abell A, Callen DF (2011) The application of delivery systems for DNA methyltransferase inhibitors. BioDrugs 25(4):227-242. doi:10.2165/11592770-000000 000-000003
13. Gore SD (2011) New ways to use DNA methyltransferase inhibitors for the treatment of myelodysplastic syndrome. Hematol Am Soc Hematol Educ Program 2011:550-555. doi: 10.1182/asheducation-2011.1.550
14. Flotho C, Claus R, Batz C, Schneider M, Sandrock I, Ihde S, Plass C, Niemeyer CM, Lubbert M (2009) The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells. Leukemia 23(6):1019-1028. doi:10.1038/leu.2008. 397
15. Savickiene J, Treigyte G, Jonusiene V, Bruzaite R, Borutinskaite VV, Navakauskiene R (2012) Epigenetic changes by zebularine leading to enhanced differentiation of human promyelocytic leukemia NB4 and KG1 cells. Mol Cell Biochem 359(1-2):245-261. doi:10.1007/s11010-011-1019-7
16. Xiong H, Chen ZF, Liang QC, Du W, Chen HM, Su WY, Chen GQ, Han ZG, Fang JY (2009) Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signaling. J Cell Mol Med. doi:10.1111/j.1582-4934.2008.00661.x
17. Cui M, Wen Z, Chen J, Yang Z, Zhang H (2010) 5-Aza-2'-deoxycytidine is a potent inhibitor of DNA methyltransferase 3B and induces apoptosis in human endometrial cancer cell lines with the up-regulation of hMLH1. Med Oncol 27(2):278-285. doi:10.1007/s12032-009-9204-1
18. Vivaldi A, Miasaki FY, Ciampi R, Agate L, Collecchi P, Capodanno A, Pinchera A, Elisei R (2009) Re-differentiation of thyroid carcinoma cell lines treated with 5-Aza-2'-deoxycytidine and retinoic acid. Mol Cell Endocrinol 307(1-2):142-148. doi: 10.1016/j.mce.2009.03.020
19. Ruiz-Magana MJ, Rodriguez-Vargas JM, Morales JC, Saldivia MA, Schulze-Osthoff K, Ruiz-Ruiz C (2011) The DNA methyltransferase inhibitors zebularine and decitabine induce mitochondria-mediated apoptosis and DNA damage in p53 mutant leukemic T cells. Int J Cancer. doi:10.1002/ijc.26107
20. Gao S, Mobley A, Miller C, Boklan J, Chandra J (2008) Potentiation of reactive oxygen species is a marker for synergistic cytotoxicity of MS-275 and 5-azacytidine in leukemic cells. Leuk Res 32(5):771-780. doi:10.1016/j.leukres. 2007.09.007
21. Bogurcu N, Sevimli-Gur C, Ozmen B, Bedir E, Korkmaz KS (2011) ALCAPs induce mitochondrial apoptosis and activate DNA damage response by generating ROS and inhibiting topoisomerase I enzyme activityinK562 leukemia cell line. Biochem Biophys Res Commun 409(4):738-744. doi:10.1016/j.bbrc.2011.05.078
22. Ravindran J, Gupta N, Agrawal M, Bala Bhaskar AS, Lakshmana Rao PV (2011) Modulation of ROS/MAPK signaling pathways by okadaic acid leads to cell death via, mitochondrial mediated caspase-dependent mechanism. Apoptosis 16(2):145-161. doi: 10.1007/s10495-010-0554-0
23. Mazumder Indra D, Singh RK, Mitra S, Dutta S, Chakraborty C, Basu PS, Mondal RK, Roychoudhury S, Panda CK (2011) Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression. Gynecol Oncol 123(3):597-604. doi:10.1016/j.ygyno. 2011.08.004
24. Kang S, Kim JW, Kang GH, Lee S, Park NH, Song YS, Park SY, Kang SB, Lee HP (2006) Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma. Int J Cancer 118(9):2168-2171. doi:10.1002/ijc.21609
25. Ben-Kasus T, Ben-Zvi Z, Marquez VE, Kelley JA, Agbaria R (2005) Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells. Biochem Pharmacol 70(1):121-133. doi:10.1016/j.bcp. 2005.04.010
26. Billam M, Sobolewski MD, Davidson NE (2010) Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells. Breast Cancer Res Treat 120(3):581-592. doi: 10.1007/s10549-009-0420-3
27. Park WH, Seol JG, Kim ES, Hyun JM, Jung CW, Lee CC, Kim BK, Lee YY (2000) Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res 60(11):3065-3071
28. Han YH, Kim SW, Kim SH, Kim SZ, Park WH (2008) 2, 4-Dinitrophenol induces G1 phase arrest and apoptosis in human pulmonary adenocarcinoma Calu-6 cells. Toxicol in Vitro 22(3):659-670. doi:10.1016/j.tiv. 2007.12.005
29. Han YH, Kim SZ, Kim SH, Park WH (2008) Apoptosis in pyrogallol-treated Calu-6 cells is correlated with the changes of intracellular GSH levels rather than ROS levels. Lung Cancer 59(3):301-314. doi:10.1016/j.lungcan. 2007.08.034
30. Han YH, Kim SZ, Kim SH, Park WH (2007) Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis. Am J Physiol Renal Physiol 293(2):F511-F520. doi:10.1152/ajprenal. 00385.2006
31. Han YH, Kim SH, Kim SZ, Park WH (2008) Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion. Int J Oncol 33(5):1099-1105
32. Fandy TE (2009) Development of DNA methyltransferase inhibitors for the treatment of neoplastic diseases. Curr Med Chem 16(17):2075-2085
33. Cheng JC, Weisenberger DJ, Gonzales FA, Liang G, Xu GL, Hu YG, Marquez VE, Jones PA (2004) Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells. Mol Cell Biol 24(3):1270-1278
34. Schnelldorfer T, Gansauge S, Gansauge F, Schlosser S, Beger HG, Nussler AK (2000) Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer 89(7):1440-1447. doi:10.1002/1097-0142 (20001001) 89:7<1440:AID-CNCR5>3.0. CO;2-0
35. Brechbuhl HM, Kachadourian R, Min E, Chan D, Day BJ (2011) Chrysin enhances doxorubicin-induced cytotoxicity in human lung epithelial cancer cell lines: The role of glutathione. Toxicol Appl Pharmacol. doi:10.1016/j.taap. 2011.08.004
36. Fath MA, Ahmad IM, Smith CJ, Spence J, Spitz DR (2011) Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism. Clin Cancer Res 17(19):6206-6217. doi:10.1158/1078-0432. CCR-11-0736